Department of Pathology Microbiology and Immunology
-
January 31, 2019
Designing antibodies to fight the flu
Vanderbilt investigators said their work shows that computational design can improve the ability of naturally occurring antibodies to recognize different flu strains and may hasten the development of more effective flu therapies and vaccines. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
December 13, 2018
RNA processing and antiviral immunity
John Karijolich and colleagues have discovered a link between cellular RNA processing and the innate cellular immune response to viral pathogens. -
December 6, 2018
Discovery could lead to neutralizing West Nile virus
Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can “neutralize” the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States. -
November 1, 2018
Team’s findings show glutamine metabolism affects T cell signaling
The cellular nutrient glutamine launches a metabolic signaling pathway that promotes the function of some immune system T cells and suppresses others, Vanderbilt researchers have discovered. -
November 1, 2018
Rubin receives alumni award from Weill Cornell
Donald Rubin, MD, professor of Medicine and Pathology, Microbiology and Immunology at Vanderbilt, has received the alumni award for special achievement from his alma mater, the Weill Cornell Medical College in New York City. -
October 12, 2018
Asthma’s androgen connection
New findings may explain why the prevalence of asthma is higher in women and suggest that testosterone derivatives may be useful for treating more severe types of asthma.